McIlrath & Eck’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-397
| Closed | -$185K | – | 1032 |
|
|
2024
Q3 | $185K | Hold |
397
| – | – | 0.02% | 127 |
|
|
2024
Q2 | $186K | Hold |
397
| – | – | 0.03% | 123 |
|
|
2024
Q1 | $166K | Buy |
397
+91
| +30% | +$38.5K | 0.03% | 127 |
|
|
2023
Q4 | $125K | Sell |
306
-91
| -23% | -$33.6K | 0.02% | 148 |
|
|
2023
Q3 | $138K | Hold |
397
| – | – | 0.03% | 136 |
|
|
2023
Q2 | $140K | Sell |
397
-9
| -2% | -$3.03K | 0.03% | 131 |
|
|
2023
Q1 | $128K | Buy |
406
+9
| +2% | +$2.7K | 0.03% | 134 |
|
|
2022
Q4 | $115K | Hold |
397
| – | – | 0.03% | 136 |
|
|
2022
Q3 | $115K | Hold |
397
| – | – | 0.03% | 132 |
|
|
2022
Q2 | $112K | Hold |
397
| – | – | 0.03% | 122 |
|
|
2022
Q1 | $104K | Hold |
397
| – | – | 0.03% | 134 |
|
|
2021
Q4 | $87K | Hold |
397
| – | – | 0.02% | 165 |
|
|
2021
Q3 | $72K | Sell |
397
-215
| -35% | -$42K | 0.02% | 183 |
|
|
2021
Q2 | $123K | Buy |
612
+299
| +96% | +$62.5K | 0.04% | 129 |
|
|
2021
Q1 | $67K | Buy |
313
+306
| +4,371% | +$67.2K | 0.02% | 167 |
|
|
2020
Q4 | $2K | Hold |
7
| – | – | ﹤0.01% | 634 |
|
|
2020
Q3 | $2K | Hold |
7
| – | – | ﹤0.01% | 612 |
|
|
2020
Q2 | $2K | Hold |
7
| – | – | ﹤0.01% | 611 |
|
|
2020
Q1 | $2K | Sell |
7
-4
| -36% | -$918 | ﹤0.01% | 588 |
|
|
2019
Q4 | $2K | Buy |
11
+4
| +57% | +$810 | ﹤0.01% | 580 |
|
|
2019
Q3 | $1K | Hold |
7
| – | – | ﹤0.01% | 609 |
|
|
2019
Q2 | $1K | Hold |
7
| – | – | ﹤0.01% | 601 |
|
|
2019
Q1 | $1K | Hold |
7
| – | – | ﹤0.01% | 601 |
|
|
2018
Q4 | $1K | Hold |
7
| – | – | ﹤0.01% | 520 |
|
|
2018
Q3 | $1K | Hold |
7
| – | – | ﹤0.01% | 516 |
|
|
2018
Q2 | $1K | Hold |
7
| – | – | ﹤0.01% | 497 |
|
|
2018
Q1 | $1K | Hold |
7
| – | – | ﹤0.01% | 461 |
|
|
2017
Q4 | $1K | Buy |
+7
| New | +$1.04K | ﹤0.01% | 501 |
|
Other funds holding VRTX
